HeartFlow, Inc. is a medical technology company that develops non-invasive cardiac imaging solutions using advanced computational fluid dynamics and artificial intelligence to assess coronary artery disease. Its flagship HeartFlow FFRct Analysis transforms standard coronary CT scans into a 3D model of the patient’s coronary arteries to help clinicians evaluate blood flow and determine the severity of blockages. The company aims to improve cardiovascular diagnosis and treatment planning while reducing unnecessary invasive procedures.
HeartFlow integrates advanced AI, deep learning, and computational fluid dynamics with coronary CT imaging to provide non-invasive, quantitative assessments of coronary artery disease. Its strategy focuses on generating clinically validated, regulatory-approved decision-support tools that fit into existing cardiology workflows, supported by large-scale clinical evidence and partnerships with major health systems and imaging vendors.
Collaboration to integrate HeartFlow FFRct Analysis with Siemens Healthineers’ cardiac CT imaging platforms to streamline non-invasive assessment of coronary artery disease.
Technology integration to make HeartFlow’s FFRct Analysis available through GE Healthcare’s CT imaging ecosystem, improving access to non-invasive coronary physiology assessment.